<?xml version="1.0" encoding="UTF-8"?>
<doi_batch version="4.3.5" 
	xmlns="http://www.crossref.org/schema/4.3.5"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xmlns:ai="http://www.crossref.org/AccessIndicators.xsd"
	xmlns:fr="http://www.crossref.org/fundref.xsd"
	xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1"
	xsi:schemaLocation="http://www.crossref.org/schema/4.3.5 
	http://www.crossref.org/schema/deposit/crossref4.3.5.xsd">
	<head>
		<doi_batch_id>elife20140718VoR</doi_batch_id>
		<timestamp>201301221800</timestamp>
		<depositor>
			<depositor_name>TNQ</depositor_name>
			<email_address>production@elifesciences.org</email_address>
		</depositor>
		<registrant>eLife</registrant>
	</head>
	<body>
		<journal>
			<journal_metadata language="en">
				<full_title>eLife</full_title>
				<issn media_type="electronic">2050-084X</issn>
			</journal_metadata>
			<journal_issue>
				<publication_date media_type="online">
					<month>01</month>
					<day>22</day>
					<year>2013</year>
				</publication_date>
				<publication_date media_type="other">
					<month>02</month>
					<day>15</day>
					<year>2013</year>
				</publication_date>
				<journal_volume>
					<volume>2</volume>
				</journal_volume>
			</journal_issue>
			<journal_article publication_type="full_text">
				<titles>
					<title>NOVA-dependent regulation of cryptic NMD exons controls synaptic protein
						levels after seizure</title>
				</titles>
				<contributors>
					<person_name contributor_role="author" sequence="first">
						<given_name>Taesun</given_name>
						<surname>Eom</surname>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Chaolin</given_name>
						<surname>Zhang</surname>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Huidong</given_name>
						<surname>Wang</surname>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Kenneth</given_name>
						<surname>Lay</surname>
						<ORCID authenticated="true">http://orcid.org/0000-0000-0000-0000</ORCID>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>John</given_name>
						<surname>Fak</surname>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Jeffrey L</given_name>
						<surname>Noebels</surname>
					</person_name>
					<person_name contributor_role="author" sequence="additional">
						<given_name>Robert B</given_name>
						<surname>Darnell</surname>
					</person_name>
				</contributors>
				<jats:abstract>
					<jats:p>Bacterially-produced small molecules exert profound influences on animal health,
						morphogenesis, and evolution through poorly understood mechanisms. In one of the
						closest living relatives of animals, the choanoflagellate <jats:italic>Salpingoeca
							rosetta</jats:italic>, we find that colony development is induced by the prey
						bacterium <jats:italic>Algoriphagus machipongonensis</jats:italic> and its close relatives
						in the Bacteroidetes phylum. Here we show that a rosette inducing factor (RIF-1)
						produced by <jats:italic>A. machipongonensis</jats:italic> belongs to the small class of
						sulfonolipids, obscure relatives of the better known sphingolipids that play
						important roles in signal transmission in plants, animals and fungi. RIF-1 has
						extraordinary potency (femtomolar, or 10<jats:sup>-15</jats:sup>M) and <jats:italic>S.
							rosetta</jats:italic> can respond to it over a broad dynamic range - nine orders
						of magnitude. This study provides a prototypical example of bacterial
						sulfonolipids triggering eukaryotic morphogenesis and suggests molecular
						mechanisms through which bacteria may have contributed to the evolution of
						animals.</jats:p>
				</jats:abstract>
				<jats:abstract abstract-type="executive-summary">
					<jats:title>eLife digest</jats:title>
					<jats:p>Humans and other animals evolved in a world filled with bacteria, and bacteria
						have influenced the evolution of animals and humans. Although bacteria are most
						familiar as pathogens, they also produce small molecules that animals and other
						eukaryotes need, although the details of these beneficial effects are not well
						understood.</jats:p>
					<jats:p>The choanoflagellates are water-dwelling organisms that use their whip-like
						flagella to move around, feeding on bacteria. They can exist as one cell or a
						colony of multiple cells and, perhaps surprisingly, are the closest known living
						relatives of animals. This means that experiments on these organisms have the
						potential to improve our understanding of animal development and the transition
						from egg to embryo to adult.</jats:p>
					<jats:p>Alegado <jats:italic>et al.</jats:italic> have explored how the morphology of
						<jats:italic>Salpingoeca rosetta,</jats:italic> a colony-forming choanoflagellate, is
						influenced by its interactions with various species of bacteria. In particular,
						they find that the development of multicellularity in <jats:italic>S.
							rosetta</jats:italic>is triggered by the presence of the bacterium
						<jats:italic>Algoriphagus machipongonensis</jats:italic> as well as its close
						relatives. They also identify the signaling molecule produced by the bacteria to
						be C<jats:sub>32</jats:sub>H<jats:sub>64</jats:sub>NO<jats:sub>7</jats:sub>S; this lipid molecule is an
						obscure relative of the sphingolipid molecules that have important roles in
						signal transmission in animals, plants, and fungi. Moreover, Alegado <jats:italic>et
							al.</jats:italic> show that <jats:italic>S. rosetta</jats:italic> can respond to this
						molecule - which they call rosette-inducing factor (RIF-1) - over a wide range
						of concentrations, including concentrations as low as 10<jats:sub>-17</jats:sub>M.</jats:p>
					<jats:p>The work of Alegado <jats:italic>et al.</jats:italic> suggests that interactions between
						<jats:italic>S. rosetta</jats:italic> and <jats:italic>Algoriphagus</jats:italic> bacteria could
						be a productive model system for studying the influences of bacteria on animal
						cell biology and for investigating the mechanisms of signal delivery and
						reception. Moreover, the molecular mechanisms revealed by this work leave open
						the possibility that bacteria might have contributed to the evolution of
						multicellularity in animals.</jats:p>
				</jats:abstract>
				<publication_date media_type="online">
					<month>01</month>
					<day>22</day>
					<year>2013</year>
				</publication_date>
				<publisher_item>
					<identifier id_type="doi">10.7554/eLife.00178</identifier>
				</publisher_item>
				<fr:program name="fundref">
					<fr:assertion name="fundgroup">
						<fr:assertion name="funder_name">Howard Hughes Medical Institute
							<fr:assertion name="funder_identifier">100000011</fr:assertion>
						</fr:assertion>
					</fr:assertion>
					<fr:assertion name="fundgroup">
						<fr:assertion name="funder_name">National Institutes of Health
							<fr:assertion name="funder_identifier">100000002</fr:assertion>
						</fr:assertion>
						<fr:assertion name="award_number">DK083531</fr:assertion>
					</fr:assertion>
					<fr:assertion name="fundgroup">
						<fr:assertion name="funder_name">National Institutes of Health
							<fr:assertion name="funder_identifier">100000002</fr:assertion>
						</fr:assertion>
						<fr:assertion name="award_number">DK041096</fr:assertion>
					</fr:assertion>
					<fr:assertion name="fundgroup">
						<fr:assertion name="funder_name">JPB Foundation
							<fr:assertion name="funder_identifier">100007457</fr:assertion>
						</fr:assertion>
					</fr:assertion>
				</fr:program>
				<ai:program name="AccessIndicators">
						<ai:license_ref applies_to="vor">http://creativecommons.org/licenses/by/4.0/</ai:license_ref>
						<ai:license_ref applies_to="am">http://creativecommons.org/licenses/by/4.0/</ai:license_ref>
						<ai:license_ref applies_to="tdm">http://creativecommons.org/licenses/by/4.0/</ai:license_ref>
					</ai:program>
				<archive_locations>
					<archive name="CLOCKSS"/>
				</archive_locations>
				<doi_data>
					<doi>10.7554/eLife.00178</doi>
					<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178</resource>
					<collection property="text-mining">
						<item>
							<resource content_version="vor" mime_type="application/pdf">http://elifesciences.org/lookup/doi/10.7554/eLife.00178</resource>
						</item>
						<item>
							<resource content_version="am">http://elifesciences.org/lookup/doi/10.7554/eLife.00178</resource>
						</item>
					</collection>
				</doi_data>
				<citation_list>
                    <citation key="1">
                        <journal_title>J Muscle Res Cell Motil</journal_title>
                        <author>Adio</author>
                        <volume>27</volume>
                        <first_page>153</first_page>
                        <cYear>2006</cYear>
                        <doi>10.1007/s10974-005-9054-1</doi>
                    </citation>
                    <citation key="2">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Andrews</author>
                        <volume>90</volume>
                        <first_page>6503</first_page>
                        <cYear>1993</cYear>
                        <doi>10.1073/pnas.90.14.6503</doi>
                    </citation>
                    <citation key="3">
                        <journal_title>Neuron</journal_title>
                        <author>Baas</author>
                        <volume>22</volume>
                        <first_page>23</first_page>
                        <cYear>1999</cYear>
                        <doi>10.1016/S0896-6273(00)80675-3</doi>
                    </citation>
                    <citation key="4">
                        <journal_title>Nat Cell Biol</journal_title>
                        <author>Baas</author>
                        <volume>4</volume>
                        <first_page>E194</first_page>
                        <cYear>2002</cYear>
                        <doi>10.1038/ncb0802-e194</doi>
                    </citation>
                    <citation key="5">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Baas</author>
                        <volume>85</volume>
                        <first_page>8335</first_page>
                        <cYear>1988</cYear>
                        <doi>10.1073/pnas.85.21.8335</doi>
                    </citation>
                    <citation key="6">
                        <journal_title>Dev Neurobiol</journal_title>
                        <author>Baas</author>
                        <volume>71</volume>
                        <first_page>403</first_page>
                        <cYear>2011</cYear>
                        <doi>10.1002/dneu.20818</doi>
                    </citation>
                    <citation key="7">
                        <journal_title>Traffic</journal_title>
                        <author>Baas</author>
                        <volume>7</volume>
                        <first_page>490</first_page>
                        <cYear>2006</cYear>
                        <doi>10.1111/j.1600-0854.2006.00392.x</doi>
                    </citation>
                    <citation key="8">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Baas</author>
                        <volume>84</volume>
                        <first_page>5272</first_page>
                        <cYear>1987</cYear>
                        <doi>10.1073/pnas.84.15.5272</doi>
                    </citation>
                    <citation key="9">
                        <journal_title>J Neurosci</journal_title>
                        <author>Barbagallo</author>
                        <volume>30</volume>
                        <first_page>13932</first_page>
                        <cYear>2010</cYear>
                        <doi>10.1523/JNEUROSCI.1515-10.2010</doi>
                    </citation>
                    <citation key="10">
                        <journal_title>Structure</journal_title>
                        <author>Chretien</author>
                        <volume>4</volume>
                        <first_page>1031</first_page>
                        <cYear>1996</cYear>
                        <doi>10.1016/S0969-2126(96)00110-4</doi>
                    </citation>
                    <citation key="11">
                        <journal_title>Development</journal_title>
                        <author>Clark</author>
                        <volume>124</volume>
                        <first_page>461</first_page>
                        <cYear>1997</cYear>
                    </citation>
                    <citation key="12">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Dietrich</author>
                        <volume>105</volume>
                        <first_page>8938</first_page>
                        <cYear>2008</cYear>
                        <doi>10.1073/pnas.0803575105</doi>
                    </citation>
                    <citation key="13">
                        <journal_title>Genes Dev</journal_title>
                        <author>Gao</author>
                        <volume>13</volume>
                        <first_page>2549</first_page>
                        <cYear>1999</cYear>
                        <doi>10.1101/gad.13.19.2549</doi>
                    </citation>
                    <citation key="14">
                        <journal_title>J Neurosci</journal_title>
                        <author>Guillaud</author>
                        <volume>23</volume>
                        <first_page>131</first_page>
                        <cYear>2003</cYear>
                    </citation>
                    <citation key="15">
                        <journal_title>Cell</journal_title>
                        <author>Hall</author>
                        <volume>65</volume>
                        <first_page>837</first_page>
                        <cYear>1991</cYear>
                        <doi>10.1016/0092-8674(91)90391-B</doi>
                    </citation>
                    <citation key="16">
                        <journal_title>J Cell Biol</journal_title>
                        <author>Hedstrom</author>
                        <volume>183</volume>
                        <first_page>635</first_page>
                        <cYear>2008</cYear>
                        <doi>10.1083/jcb.200806112</doi>
                    </citation>
                    <citation key="17">
                        <journal_title>Cell</journal_title>
                        <author>Hirokawa</author>
                        <volume>56</volume>
                        <first_page>867</first_page>
                        <cYear>1989</cYear>
                        <doi>10.1016/0092-8674(89)90691-0</doi>
                    </citation>
                    <citation key="18">
                        <journal_title>Nat Rev Neurosci</journal_title>
                        <author>Hirokawa</author>
                        <volume>6</volume>
                        <first_page>201</first_page>
                        <cYear>2005</cYear>
                        <doi>10.1038/nrn1624</doi>
                    </citation>
                    <citation key="19">
                        <journal_title>Trends Cell Biol</journal_title>
                        <author>Hoogenraad</author>
                        <volume>19</volume>
                        <first_page>669</first_page>
                        <cYear>2009</cYear>
                        <doi>10.1016/j.tcb.2009.08.006</doi>
                    </citation>
                    <citation key="20">
                        <journal_title>Nature</journal_title>
                        <author>Howard</author>
                        <volume>422</volume>
                        <first_page>753</first_page>
                        <cYear>2003</cYear>
                        <doi>10.1038/nature01600</doi>
                    </citation>
                    <citation key="21">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Jolly</author>
                        <volume>107</volume>
                        <first_page>12151</first_page>
                        <cYear>2010</cYear>
                        <doi>10.1073/pnas.1004736107</doi>
                    </citation>
                    <citation key="22">
                        <journal_title>Mol Cell Neurosci</journal_title>
                        <author>Kapitein</author>
                        <volume>46</volume>
                        <first_page>9</first_page>
                        <cYear>2011</cYear>
                        <doi>10.1016/j.mcn.2010.08.015</doi>
                    </citation>
                    <citation key="23">
                        <journal_title>Curr Biol</journal_title>
                        <author>Kapitein</author>
                        <volume>20</volume>
                        <first_page>290</first_page>
                        <cYear>2010</cYear>
                        <doi>10.1016/j.cub.2009.12.052</doi>
                    </citation>
                    <citation key="24">
                        <journal_title>Annu Rev Neurosci</journal_title>
                        <author>Kennedy</author>
                        <volume>29</volume>
                        <first_page>325</first_page>
                        <cYear>2006</cYear>
                        <doi>10.1146/annurev.neuro.29.051605.112808</doi>
                    </citation>
                    <citation key="25">
                        <journal_title>Cell</journal_title>
                        <author>Klassen</author>
                        <volume>130</volume>
                        <first_page>704</first_page>
                        <cYear>2007</cYear>
                        <doi>10.1016/j.cell.2007.06.046</doi>
                    </citation>
                    <citation key="26">
                        <journal_title>Neural Dev</journal_title>
                        <author>Kollins</author>
                        <volume>4</volume>
                        <first_page>26</first_page>
                        <cYear>2009</cYear>
                        <doi>10.1186/1749-8104-4-26</doi>
                    </citation>
                    <citation key="27">
                        <journal_title>Nat Neurosci</journal_title>
                        <author>Maniar</author>
                        <volume>15</volume>
                        <first_page>48</first_page>
                        <cYear>2012</cYear>
                        <doi>10.1038/nn.2970</doi>
                    </citation>
                    <citation key="28">
                        <journal_title>J Cell Biol</journal_title>
                        <author>Marszalek</author>
                        <volume>145</volume>
                        <first_page>469</first_page>
                        <cYear>1999</cYear>
                        <doi>10.1083/jcb.145.3.469</doi>
                    </citation>
                    <citation key="29">
                        <journal_title>Curr Biol</journal_title>
                        <author>Mattie</author>
                        <volume>20</volume>
                        <first_page>2169</first_page>
                        <cYear>2010</cYear>
                        <doi>10.1016/j.cub.2010.11.050</doi>
                    </citation>
                    <citation key="30">
                        <journal_title>J Cell Biol</journal_title>
                        <author>Navone</author>
                        <volume>117</volume>
                        <first_page>1263</first_page>
                        <cYear>1992</cYear>
                        <doi>10.1083/jcb.117.6.1263</doi>
                    </citation>
                    <citation key="31">
                        <journal_title>Cell</journal_title>
                        <author>Ou</author>
                        <volume>141</volume>
                        <first_page>846</first_page>
                        <cYear>2010</cYear>
                        <doi>10.1016/j.cell.2010.04.011</doi>
                    </citation>
                    <citation key="32">
                        <journal_title>Development</journal_title>
                        <author>Palacios</author>
                        <volume>129</volume>
                        <first_page>5473</first_page>
                        <cYear>2002</cYear>
                        <doi>10.1242/dev.00119</doi>
                    </citation>
                    <citation key="33">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Patel</author>
                        <volume>90</volume>
                        <first_page>9181</first_page>
                        <cYear>1993</cYear>
                        <doi>10.1073/pnas.90.19.9181</doi>
                    </citation>
                    <citation key="34">
                        <journal_title>Neural Dev</journal_title>
                        <author>Rolls</author>
                        <volume>2</volume>
                        <first_page>7</first_page>
                        <cYear>2007</cYear>
                        <doi>10.1186/1749-8104-2-7</doi>
                    </citation>
                    <citation key="35">
                        <journal_title>Neuron</journal_title>
                        <author>Saito</author>
                        <volume>18</volume>
                        <first_page>425</first_page>
                        <cYear>1997</cYear>
                        <doi>10.1016/S0896-6273(00)81243-X</doi>
                    </citation>
                    <citation key="36">
                        <journal_title>J Biol Chem</journal_title>
                        <author>Seeger</author>
                        <volume>285</volume>
                        <first_page>8155</first_page>
                        <cYear>2010</cYear>
                    </citation>
                    <citation key="37">
                        <journal_title>Traffic</journal_title>
                        <author>Siddiqui</author>
                        <volume>3</volume>
                        <first_page>20</first_page>
                        <cYear>2002</cYear>
                        <doi>10.1034/j.1600-0854.2002.30104.x</doi>
                    </citation>
                    <citation key="38">
                        <journal_title>Nature</journal_title>
                        <author>Sieburth</author>
                        <volume>436</volume>
                        <first_page>510</first_page>
                        <cYear>2005</cYear>
                        <doi>10.1038/nature03809</doi>
                    </citation>
                    <citation key="39">
                        <journal_title>Methods Enzymol</journal_title>
                        <author>Sloboda</author>
                        <volume>85</volume>
                        <first_page>409</first_page>
                        <cYear>1982</cYear>
                    </citation>
                    <citation key="40">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Sobotzik</author>
                        <volume>106</volume>
                        <first_page>17564</first_page>
                        <cYear>2009</cYear>
                        <doi>10.1073/pnas.0909267106</doi>
                    </citation>
                    <citation key="41">
                        <journal_title>J Neurosci</journal_title>
                        <author>Stepanova</author>
                        <volume>23</volume>
                        <first_page>2655</first_page>
                        <cYear>2003</cYear>
                    </citation>
                    <citation key="42">
                        <journal_title>Mol Biol Cell</journal_title>
                        <author>Stone</author>
                        <volume>19</volume>
                        <first_page>4122</first_page>
                        <cYear>2008</cYear>
                        <doi>10.1091/mbc.E07-10-1079</doi>
                    </citation>
                    <citation key="43">
                        <journal_title>Cell</journal_title>
                        <author>Sym</author>
                        <volume>98</volume>
                        <first_page>25</first_page>
                        <cYear>1999</cYear>
                        <doi>10.1016/S0092-8674(00)80603-0</doi>
                    </citation>
                    <citation key="44">
                        <journal_title>Nat Neurosci</journal_title>
                        <author>Teichmann</author>
                        <volume>14</volume>
                        <first_page>165</first_page>
                        <cYear>2011</cYear>
                        <doi>10.1038/Nn.2717</doi>
                    </citation>
                    <citation key="53">
                        <journal_title>Proc Natl Acad Sci USA</journal_title>
                        <author>Ueno</author>
                        <volume>105</volume>
                        <first_page>19702</first_page>
                        <cYear>2008</cYear>
                        <doi>10.1073/pnas.0808194105</doi>
                    </citation>
                    <citation key="45">
                        <journal_title>Cell</journal_title>
                        <author>Vale</author>
                        <volume>112</volume>
                        <first_page>467</first_page>
                        <cYear>2003</cYear>
                        <doi>10.1016/S0092-8674(03)00111-9</doi>
                    </citation>
                    <citation key="46">
                        <journal_title>Methods Enzymol</journal_title>
                        <author>Wagner</author>
                        <volume>196</volume>
                        <first_page>157</first_page>
                        <cYear>1991</cYear>
                        <doi>10.1016/0076-6879(91)96016-K</doi>
                    </citation>
                    <citation key="47">
                        <journal_title>Philos Trans R Soc Lond B Biol Sci</journal_title>
                        <author>White</author>
                        <volume>275</volume>
                        <first_page>327</first_page>
                        <cYear>1976</cYear>
                        <doi>10.1098/rstb.1976.0086</doi>
                    </citation>
                    <citation key="48">
                        <journal_title>EMBO J</journal_title>
                        <author>Yamada</author>
                        <volume>29</volume>
                        <first_page>517</first_page>
                        <cYear>2010</cYear>
                        <doi>10.1038/emboj.2009.378</doi>
                    </citation>
                    <citation key="49">
                        <journal_title>J Cell Biol</journal_title>
                        <author>Yang</author>
                        <volume>169</volume>
                        <first_page>447</first_page>
                        <cYear>2005</cYear>
                        <doi>10.1083/jcb.200411132</doi>
                    </citation>
                    <citation key="50">
                        <journal_title>J Struct Biol</journal_title>
                        <author>Yasunaga</author>
                        <volume>116</volume>
                        <first_page>155</first_page>
                        <cYear>1996</cYear>
                        <doi>10.1006/jsbi.1996.0025</doi>
                    </citation>
                    <citation key="51">
                        <journal_title>J Electron Microsc (Tokyo)</journal_title>
                        <author>Yasunaga</author>
                        <volume>57</volume>
                        <first_page>101</first_page>
                        <cYear>2008</cYear>
                        <doi>10.1093/jmicro/dfn006</doi>
                    </citation>
                    <citation key="52">
                        <journal_title>Nat Cell Biol</journal_title>
                        <author>Zheng</author>
                        <volume>10</volume>
                        <first_page>1172</first_page>
                        <cYear>2008</cYear>
                        <doi>10.1038/ncb1777</doi>
                    </citation>
                </citation_list>
				<component_list>
					<component parent_relation="isPartOf">
						<titles>
							<title>Abstract</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.001</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.001</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>eLife digest</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.002</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.002</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1. NOVA proteins up/down-regulate transcript levels.</title>
							<subtitle>(<b>A</b>)
								Affymetrix exon arrays were interrogated with RNA from WT vs DKO
								E18.5 mouse whole brains, and normalized transcript intensities were
								plotted in log<sub>2</sub> scale (log<sub>2</sub>(WT/DKO) &#x3e; 0.3
								or &#x2212;0.3 and p&#x3c;0.05). The X-axis indicates ranks of
								transcripts from the top and Y-axis is the measure of relative
								transcript levels (WT/DKO) in log<sub>2</sub> scale. Blue bracket
								represents transcripts whose levels are increased in WT relative to
								DKO brain (NOVA-dependent &#x2018;upregulation&#x2019; of
								steady-state mRNA levels), and the purple bracket represents
								down-regulated transcripts in WT relative to DKO (NOVA-dependent
								repression of steady-state mRNA levels). (<b>B</b>),(<b>C</b>)
								qRT-PCR data of representative NOVA regulated transcripts. Y-axis
								represents the mRNA levels in which WT is normalized to 1.0. Data is
								from three biologic replicates (three animals) and three technical
								replicates (nine reactions per point); error bars represent standard
								deviation. For each point p&#x3c;0.001; see Table 1 for additional
								data. NOVA up-regulated transcripts in WT versus DKO (<b>B</b>;
								corresponding to blue bracket in Figure 1A) and NOVA down-regulated
								transcripts (<b>C</b>; corresponding to purple bracket in Figure 1A)
								are shown. (<b>D</b>) Immunoblot analysis of NOVA distribution in
								nuclear and cytoplasmic fractions from mouse brain irradiated by UV.
								Each lane represents the different brain extracts as biological
								replicates. HSP90 is used as a cytoplasmic marker, and hnRNP-C1/C2
								as a nuclear marker. The NOVA2 antibody detects both large and small
								NOVA2 isoforms (Yang et al., 1998). (<b>E</b>) Breakdown of BC
								&#x3d; 4 clusters for nuclear and cytoplasmic Nova HITS-CLIP.
								Downstream 10K clusters are enriched in unannotated 3&#x2032; UTRs
								(Licatalosi et al., 2008); see also Table 2. (<b>F</b>) Distribution
								of BC &#x3d; 4 clusters by peak height for both nuclear and
								cytoplasmic HITS-CLIP; more stringent cytoplasmic clusters show
								enrichment in 3&#x2032; UTR. (<b>G</b>) Distribution of CLIP tags
								(intronic, red; 3&#x2032; UTR, blue) from the list of NOVA
								up-regulated RNAs. Each point on the X-axis represents a
								Nova-dependent gene (in arbitrary order) and Y-axis represents the
								percentage of intronic/3&#x2032; UTR tags for transcripts with total
								tags &#x3e;5.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<ai:program>
							<ai:license_ref>© 1977 Thieme Medical Publishers. All Rights Reserved. Figure 1, lower panel, is reproduced from Hughes and Sperandio, 2008 with permission.</ai:license_ref>
							<ai:license_ref>© 2007 Elsevier Masson SAS. All rights reserved. The patient figure in Figure 6, part A is reproduced from Koropatnick et al., 2004, European Journal of Medical Genetics with permission.</ai:license_ref>
							</ai:program>
						<doi_data>
							<doi>10.7554/eLife.00178.003</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.003</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1&#x2014;figure supplement 1. Nova CLIP results.</title>
							 <subtitle>Nuclear (Nuc, blue; upper) and cytoplasmic
								(Cyt, red; lower) HITS-CLIP tags are shown. All unique tags from
								nuclear and cytoplasmic HITS-CLIP clusters were plotted onto the
								whole genome and showed a relatively low correlation (R<sup>2</sup>
								&#x3d; 0.32). By comparison, two independent cytoplasmic HITS-CLIP
								tags showed higher R<sup>2</sup> values (0.765; data not shown).
									(<b>B</b>) BC4 clusters were grouped according to each gene, and
							 	CLIP tags <!-- commented out math ml. Present to demonstrate how it would appear if required -
							 		<mml:math>
									<mml:mrow>
										<mml:mo>(</mml:mo>
										<mml:msubsup>
											<mml:mrow>
												<mml:mtext>NO</mml:mtext>
											</mml:mrow>
											<mml:mn>3</mml:mn>
											<mml:mo>-</mml:mo>
										</mml:msubsup>
										<mml:mo>)</mml:mo>
									</mml:mrow>
								</mml:math> --> from these clusters were summed up gene-by-gene for each
								individual experiment, to obtain the total number of BC4 tags for
								each gene. The first plot (Cyt total vs Nuc total) shows the
								correlation (R<sup>2</sup> &#x3d; 0.36) between the total number of
								nuclear CLIP tags per gene and the total number of cytoplasmic tags
								per gene; each point represents a gene. The other two plots are
								similar but the correlations were calculated using two Nuc CLIP
								experiments or two Cyt CLIP experiments.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.004</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.004</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 1&#x2014;figure supplement 2. Correlations: analysis of Nova CLIP results.</title>
								<subtitle> NOVA HITS-CLIP
								BC4 clusters were grouped according to each gene, and CLIP tags from
								these clusters were summed up gene-by-gene for each individual
								experiment, to obtain the total number of BC4 tags for each gene.
								The first plot (Cyt total vs Nuc total) shows the 
								<!-- commented out math ml. Present to demonstrate how it would appear if required -<mml:math>
									<mml:mrow>
										<mml:mo>(</mml:mo>
										<mml:msubsup>
											<mml:mrow>
												<mml:mtext>NO</mml:mtext>
											</mml:mrow>
											<mml:mn>3</mml:mn>
											<mml:mo>-</mml:mo>
										</mml:msubsup>
										<mml:mo>)</mml:mo>
									</mml:mrow>
								</mml:math> -->
									correlation (R<sup>2</sup> &#x3d; 0.36) between the
								total number of nuclear CLIP tags per gene and the total number of
								cytoplasmic tags per gene; each point represents a gene. The other
								two plots are similar but the correlations were calculated using two
								Nuc CLIP experiments or two Cyt CLIP experiments. </subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.005</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.005</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Table 1. Validation data for transcripts showing
								Nova-dependent changes in steady-state mRNA levels</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.006</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.006</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Table 2. Summary of CLIP tag mapping data</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.007</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.007</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 2. NOVA regulates the expression of <i>Dlg3</i> mRNA and
									protein.</title>
							<subtitle>(<b>A</b>) Location of NOVA cytoplasmic and nuclear
								CLIP tags in chromosome X:96591589-99424482. Red and purple colors
								represent cytoplasmic CLIP tags and green and blue colors represent
								nuclear CLIP tags. The location of <i>Dlg3</i> is boxed in black and
								magnified in the lower box (chromosomeX:98002207-98013864). This
								higher magnification illustrates the position of <i>Dlg3</i>
								constitutive (yellow), alternative (colored) exons and 3&#x2032; UTR
								(brown) relative to CLIP tags, YCAY elements, and sequence
								conservation across species. More cytoplasmic tags were evident in
								the 3&#x2032; UTR and more nuclear tags in introns. Clusters of CLIP
								tags can be seen to overlap with the location of clusters of YCAY
								sequences (in grey) as well as bioinformatically predicated clusters
								of YCAY elements (in blue; see Zhang et al., 2010). (<b>B</b>)
								Northern blot analysis of <i>Dlg3</i> mRNA from three biologic
								replicates of WT or Nova KO brain mRNA. Equal amount of RNA was
								loaded (see Figure 2&#x2014;figure supplement 2). Quantitation of
								relative RNA intensity (WT/DKO) was plotted as a relative ratio of
									<i>Dlg3</i> mRNA in WT, N1 KO, N2 KO or DKO brain as indicated;
								error bars represent standard deviation (p&#x3c;0.05); about 90% of
									<i>Dlg3</i> mRNA is absent in DKO brain. (<b>C</b>) Immunoblot
								analysis of DLG3 in WT vs DKO. Protein extracts from the four
								different WT or DKO mouse brains (as indicated; E18.5) were
								assessed, and &#x3b3;-TUBULIN was used as a normalizing control.
								Quantitation of protein intensity is indicated in graph to the
								right, plotted as relative ratio of DLG3 in WT/DKO, indicate that
								&#x223c;90% of DLG3 protein is absent in DKO brain; error bars
								represent standard deviation (p&#x3c;0.05). (<b>D</b>)
								Immunofluorescence detection of DLG3 (red), NOVA (blue) and
								Neurofilament (NF) (green) proteins on WT/DKO mixed primary mouse
								neuronal cultures. DAPI and neurofilament stained all neuronal
								nuclei and processes, respectively, while NOVA staining
								differentiates WT and DKO neurons. The DLG3 signal was markedly
								reduced in DKO neurons. Scale bar: 10 &#xb5;m.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.008</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.008</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 2&#x2014;figure supplement 1. <i>Dlg3</i> mRNA isoforms in Nova KO brain.
								Northern blot analysis of <i>Dlg3</i> mRNA in WT and <i>Nova</i> DKO brain.</title>
									<subtitle>(<b>A</b>) <i>Gapdh</i> probe was used as a normalizing control.
								Panel to right: Quantitation of relative RNA intensity (WT/DKO) was
								plotted as a relative ratio of <i>Dlg3</i> mRNA/GAPDH in WT/DKO;
								error bars represent standard deviation (p&#x3c;0.05). About 75% was
								reduced in DKO.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.009</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.009</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 2&#x2014;figure supplement 2. Northern blot analysis of <i>Dlg3</i> mRNA in Nova KO
									brain-reproducibility and control.</title>
							<subtitle>Reproduction of Northern
								blot for <i>Dlg3</i> mRNA presented in Figure 2B, but also showing
								loading control below (Ethidium bromide (EtBr) stain of the gel),
								demonstrating equal loading of all RNAs.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.010</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.010</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 3. <i>Dlg3</i> mRNA is decreased through inclusion of cryptic NMD
									exons in the absence of NOVA.</title>
							<subtitle>(<b>A</b>) RT-PCR and sequence
								analysis (Figure 3&#x2014;source data 1) showed four <i>Dlg3</i>
								isoforms which have different combinations of alternatively spliced
								exons. The lower two PCR products (WT1 and WT2), respectively,
								harbor alternative exon 16 (E16) with or without E17, and both
								encode in-frame protein variants. The upper two PCR products,
								evident in DKO brain (DKO3 and DKO4), include E15, with or without
								E16, and include E17. The DKO4 isoform was not annotated in Refseq,
								and the combination of E15 and E16 led to a frameshift and inclusion
								of a premature stop codon (TAA) in E16, as indicated in the
								schematic (also leading us to color E16 red in Figure 2A). The
								15&#x2013;17 containing product does not make a premature stop
								codon. (<b>B</b>) After 6 DIV primary mouse neuronal cultures were
								treated with 100 &#x3bc;g/ml emetine for 10 hr, RNA was harvested
								from triplicate samples and analyzed by RT-PCR. Emetine treatment
								had no effect cell viability nor on isoforms produced in WT cells,
								but led to accumulation of the NMD isoform DKO4 in Nova DKO neurons.
								Spliced isoforms are indicated. (<b>C</b>) siRNA to Upf1 was
								transfected into DKO mouse primary cells, and after 24 hr, DLG3
								(red) and UPF1 (green) protein was detected by immunofluorescence
								microscopy. Arrows indicate cells that have relatively high UPF1
								levels; these cells have low DLG3 levels. In contrast, cells
								transfected with Upf1 siRNA (asterisks) had markedly reduced Upf1
								levels and had increased (rescued) DLG3 levels. Upper and lower rows
								represent independent experiments. Scale bar: 10 &#xb5;m. (<b>D</b>)
								Quantitation of DLG3 signal in Upf1 positive and Upf1 knockdown
								cells in (<b>C</b>). Signal intensity was normalized to the signal
								in Upf1 positive cells. Error bar represents standard deviation
								(p&#x3c;0.05).</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.011</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.011</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 3&#x2014;source data 1. Sequence of RT-PCR products
								(from Figures 3 and 5).</title>
						</titles>
						<format mime_type="application/msword"/>
						<doi_data>
							<doi>10.7554/eLife.00178.012</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.012</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 3&#x2014;figure supplement 1. Reporter construct design for NOVA 3&#x2032; UTR actions.</title>
								<subtitle>Schematic of a reporter encoding destabilized d1EGFP and the
								3&#x2032; UTR YCAY element of NOVA&#x27;s target RNA. An identical
								construct in which the YCAY sequences were mutated to YAAY was also
								made.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.013</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.013</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 3&#x2014;figure supplement 2. NOVA increases the stability of some RNAs through binding to
									3&#x2032; UTR YCAY elements. </title>
							<subtitle>qRT-PCR was used to quantitate
								d1EGFP mRNA after transfection of various constructs (Syngr3
								[synaptogyrin 3], Glrb [Glycine receptor b], <i>Dlg3</i> and Syt2
								[Synaptotagmin 2]). Quantitation of steady state changes in RNA
								levels (YAAY relative to YCAY constructs) were 50%, 25%, 65%, 48%,
								respectively, for Syngr3, Glrb, <i>Dlg3</i> and Syt2. The Y-axis
								represents the relative mRNA levels (YCAY/YAAY). Interestingly, for
									<i>Dlg3</i>, a small 3&#x2032; UTR construct (115 nt) did not
								show any change, while a longer construct (214 nt) did, even though
								both harbored the YCAY element, suggesting that additional elements
								or RNA structures may be important for binding of NOVA to this
								3&#x2032; UTR YCAY element. Asterisks indicate p&#x3c;0.05.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.014</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.014</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 4. NOVA and NMD-mediated regulation of <i>Scn9a</i> mRNA and
									protein.</title> 
							<subtitle>(<b>A</b>) Immunoblot analysis of SCN9a in WT vs
								DKO. Proteins extracts from WT (lane 1&#x2013;3) vs DKO (lane
								4&#x2013;6) were loaded. &#x3b3;-Tubulin was used as a normalizing
								control. (<b>B</b>) Quantitation of relative protein intensity
								(WT/DKO). The results were plotted as a relative ratio of SCN9a in
								WT/DKO; error bars represent standard deviation (p&#x3c;0.05). About
								90% signal was reduced in WT. (<b>C</b>) RT-PCR from WT and DKO
								(three biologic replicates) shows NOVA-dependent splicing of
									<i>Scn9a</i>. WT brains express two alternative splicing
								isoforms (lanes 1&#x2013;3), while DKO brains express only the
								smaller isoform (lanes 4&#x2013;6). A (&#x2212;) RT control is
								indicated; primers are given in Supplementary file 2. (<b>D</b>)
								Sequence analysis and map of the spliced isoforms from Figure 4C
								showed that the larger band corresponds to a transcript in which an
								exon (17a) was included, introducing a premature stop codon. In the
								sequence shown, exon 17a is highlighted in black, and the TAA
								premature stop codon is indicated in red. (<b>E</b>) Six DIV WT
								primary mouse neuronal cultures were treated with emetine, as
								indicated, for 10 hr and RT-PCR was performed. The NMD exon was
								increased after emetine treatment. (<b>F</b>) siRNA to <i>Upf1</i>
								or a non-targeting siRNA were transfected in WT mouse primary cells,
								and RT-PCR was performed with the same primers used in Figures 4C,E.
								The intensity of the NMD exon was increased specifically after
									<i>Upf1</i> siRNA treatment.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.015</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.015</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 4&#x2014;figure supplement 1.2A cells: Upf1 siRNA efficiently reduces endogenous UPF1 protein
									levels.</title>
							<subtitle>siRNA targeting <i>Upf1</i> was transfected into N2a
								cells and immunoblot analysis of UPF1 protein was performed. Results
								from two independent experiments are shown. siRNA to <i>Upf1</i>
								showed the significant reduction of UPF1 protein expression compared
								with a control untargeting siRNA. &#x3b3;-Tubulin was used as a
								normalization control.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.016</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.016</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 4&#x2014;figure supplement 2. Primary neurons: Upf1 siRNA reduces endogenous UPF1 protein
									levels.</title>
							<subtitle>qRT-PCR quantitation of relative <i>Upf1</i> mRNA
								levels in primary neurons with or without treatment with <i>Upf1</i>
								siRNA. Error bars represents standard error of the mean; n &#x3d;
								3.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.017</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.017</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5. NOVA regulates cryptic NMD exons and transcript levels.</title>
									<subtitle>(<b>A</b>) Analysis of alternative spliced isoforms in
								transcripts chosen solely on exon array data showing NOVA-dependent
								steady-state mRNA changes and robust HITS-CLIP clusters in introns.
								Transcripts were then screened for the presence of cryptic NMD exons
								by RT-PCR using primers in exons bounding the intronic HITS-CLIP
								clusters. Data is divided into those transcripts down-regulated or
								up-regulated in Nova DKO, as indicated. Sequence analysis of RT-PCR
								products showed the presence of cryptic exons harboring premature
								stop codons (Figure 3&#x2014;source data 1; Supplementary file 2). A
								diagram of the loci of each NMD exon present in Figure 5A is shown
								in Figure 5&#x2014;figure supplement 1. For example, most
								transcripts down-regulated in Nova DKO brains show a larger, PTC
								containing exon in DKO; one exception is Actl6b, in which in the
								absence of NOVA there is a PTC, and in WT brain, an upper alternate
								isoform (exon) is present that corrects that frame-shift; (<b>B</b>)
								Effect of emetine on putative NOVA-regulated cryptic NMD exons. The
								steady-state level of six transcripts identified in Figures 3B, 4C
								and 5A were assessed by qRT-PCR in six DIV WT vs Nova DKO primary
								mouse neurons incubated for 10 hr in the presence or absence of
								emetine. The results were plotted with the Y-axis as a measure of
								the degree of putative NOVA-dependent NMD regulation (the fold
								change of transcript levels in DKO neurons in the presence or
								absence of emetine, divided by that of WT, in log<sub>2</sub>
								scale). For example, for <i>Dlg3</i> the log<sub>2</sub> value is
								about 1.0 indicating that emetine treatment increased the
									<i>Dlg3</i> NMD-isoform in DKO neurons relative to WT neurons by
								a factor of two, while emetine decreased the NMD isoform of
									<i>Scn9a</i> by &#x223c;1.4-fold, leading to decrease or
								increase in the respective proteins in Nova DKO neurons (Figures 2
								and 3 or Figure 4, respectively). Three independent experiments were
								performed and error bars represent standard deviation
								(p&#x3c;0.05).</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.018</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.018</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5&#x2014;figure supplement 1. Diagrams of each of the NMD exons shown in Figure 5A The
								position of the exon harboring a premature termination codon is
								labeled in red (PTC).</title>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.019</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.019</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 5&#x2014;figure supplement 2. NOVA regulates the expression of Stx2 (Syntaxin 2) mRNA and
									protein.</title>
							<subtitle>(<b>A</b>) RT-PCR from WT and DKO brain showed
								NOVA-dependent alternative splicing of a previously unknown, higher
								molecular weight isoform of <i>Stx2</i>. A (&#x2212;) RT negative
								control is shown. (<b>B</b>) Immunoblot analysis of STX2 protein in
								biologic triplicate samples of WT vs <i>Nova</i> DKO brain.
								&#x3b3;-Tubulin was used as a normalization control. (<b>C</b>)
								Quantitation of relative protein intensity (WT/DKO) from (<b>B</b>),
								plotted as relative ratio of STX2 in WT/DKO; error bars represent
								standard deviation (p&#x3c;0.05). (<b>D</b>) Six DIV WT primary
								mouse culture were treated with vehicle (&#x2212;) or emetine
								(&#x2b;) for 10 hr and RT-PCR was performed for Stx2 as in
								(<b>A</b>). Quantitation revealed that the NMD exon (labeled) was
								increased twofold after emetine treatment. (<b>E</b>) DY547
								direct-labeled siRNA targeting <i>Upf1</i> was transfected into WT
								mouse primary cells, and immunofluorescence microscopy used to
								detect STX2 (green) and siRNA to <i>Upf1</i> (red). The thin arrow
								(top right corner) indicates a cell which was not transfected with
									siRNA<i>,</i> and which shows a baseline signal of STX2 protein.
								The two thicker arrows indicate cells which had a good red signal
								(siRNA to <i>Upf1</i>) and stronger green signals (indicating
								increased STX2 protein). Scale bar: 10 &#xb5;m.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.020</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.020</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 6. Seizure-induced inhibition of NOVA-regulated NMD exons.</title>
									<subtitle>(<b>A</b>) Mice were treated with pilocarpine (pilo) to induce
								seizures or were mock-treated (sham). 2 hr later brains were
								harvested and splicing of NMD exons assayed by RT-PCR. (<b>B</b>)
								Quantitation of experiments described in (<b>A</b>), from three
								biologic replicates. Error bars represent standard deviation
								(p&#x3c;0.05; Student&#x27;s t-test). (<b>C</b>),(<b>D</b>) EEG of
								freely moving Nova2<sup>&#x2b;/&#x2212;</sup> mutant displays
								frequent synchronous cortical interictal discharges (<b>C</b>) not
								detected in wild type mice (<b>D</b>). (<b>E</b>) Spontaneous
								generalized seizure discharge in adult
									Nova2<sup>&#x2b;/&#x2212;</sup> mutant. A 20 s gap of continuous
								hypersynchronized EEG pattern separates the beginning and end of the
								seizure discharge. Bilateral left and right frontal, temporal,
								parietal (<b>C</b>, <b>D</b>) and occipital (<b>E</b>) leads are
								shown. Time calibration 1 s (<b>C</b>, <b>D</b>), 2 s
								(<b>E</b>).</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.021</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.021</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 6&#x2014;figure supplement 1. Comparison of different sets of transcripts regulated by
									NOVA.</title>
									<subtitle>The number of transcripts in which NOVA regulates
								alternative splicing without changing steady-state mRNA levels are
								shown in blue, and in purple transcripts showing Nova-dependent
								changes in steady-state mRNA levels (e.g. through NMD or transcript
								stability). 340 transcripts in which cassette exons are regulated by
								NOVA were compiled from previous studies (Ule et al., 2003;
								Licatalosi et al., 2008; Zhang et al., 2010), and compared with the
								211 transcripts identified here by exon array. The datasets are
								largely mutually exclusive, with only 18 transcripts in
								common.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.022</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.022</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>
								<b>Table 3.</b> Splicing changes in brain after pilocarpine-induced
								seizures</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.023</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.023</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 7.NOVA subcellular localization after pilocarpine-induced status
									epilepticus.</title>
							<subtitle>(<b>A</b>) NOVA and MAP2 protein localization
								were visualized by immunofluorescence (IF) in mouse brain sections
								from pilocarpine treated (pilo) or control animals (sham). Regions
								include CA1 and dentate gyrus (DG) from hippocampal area, cortex
								(Ctx) and cerebellar Purkinje neurons. Changes were clearly evident
								in CA1 neurons, were not evident in DG, and were variable in Ctx. No
								changes were expected nor observed in Purkinje neurons. (<b>B</b>)
								Quantification of IF signal intensity from nuclear area (Nuc)
								divided by signal intensity from cytoplasmic area (Cyt) in CA1
								neurons. Nuc/Cyt ratios (sham divided by pilocarpine signal) were
								obtained from 22 cells in two sham animals and 23 cells in four
								pilocarpine animals at the 4 hr time point. Scale bar 20
								&#x3bc;m.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.024</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.024</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 8.NOVA regulates the expression of synaptogyrin III (Syngr3) mRNA
									and protein.</title>
							<subtitle>(<b>A</b>) Location of cytoplasmic and nuclear
								CLIP for <i>Syngr3</i>. Red and purple colors represent Cytoplasmic
								CLIP tags and green and blue tags represent nuclear CLIP tags. All
								tags were located in 3&#x2032; UTR. (<b>B</b>) qRT-PCR data of
									<i>Syngr3</i>, <i>Glrb</i> (Glycine receptor b), and
									<i>Gabbr1</i> (GABA B receptor1) showed mild reduction (about
								30%) in <i>Nova</i> DKO brain. Y-axis represents the relative mRNA
								levels (WT/DKO). p&#x3c;0.05. (<b>C</b>) Northern blot analysis of
								Syngr3 mRNA in WT (lane 1, 3, 5) vs DKO (lane 2, 4, 6). Gapdh probe
								was used as a normalizing control. (<b>D</b>) Quantitation of
								relative RNA intensity (WT/DKO) was plotted as a relative ratio of
								Syngr3 mRNA/Gapdh in <i>Nova</i> WT/DKO; error bars represent
								standard deviation (p&#x3c;0.05); Syngr3 was reduced by about
								&#x223c; 20% in DKO brain. (<b>E</b>) Immunoblot analysis of SYNGR3
								in WT vs DKO. Protein extracts from WT (lane 1&#x2013;4) vs DKO
								(lane 5&#x2013;8) were loaded. &#x3b3;-TUBULIN is used as a
								normalizing control. (<b>F</b>) Quantitation of relative protein
								intensity (WT/DKO). The results were plotted as relative ratio of
								SYNGR3 in WT/DKO; error bars represent standard deviation
								(p&#x3c;0.05); SYNGR3 protein was reduced &#x223c;35% in DKO
								brain.</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.025</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.025</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Table 4. GO analysis</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.026</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.026</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>Figure 9. Model linking electrical activity with Nova-dependent splicing of
									cryptic NMD exons to maintain the balance of synaptic
									proteins.</title>
								<subtitle>In WT brain, NOVA represses some cryptic NMD
								isoforms (small red diamonds on left) while promoting others (large
								red pentagons on right), thereby maintaining the balance of protein
								levels. To a lesser degree, NOVA also stabilizes transcripts through
								3&#x2032; UTR interactions (Figure 8). In DKO brain, the absence of
								NOVA disturbs this balance of protein in expression, contributing to
								aberrations in synaptic transmission. For example, Nova-regulation
								of cryptic NMD exons alters levels of the NMDA-receptor associated
									<i>Dlg3</i> (Figures 2 and 3) and sodium channel <i>Scn9a</i>
								(Figure 4) proteins, which are implicated in familial epileptic
								disorders and are dynamically regulated after seizures in mice
								(Figure 6).</subtitle>
						</titles>
						<format mime_type="image/tiff"/>
						<doi_data>
							<doi>10.7554/eLife.00178.017</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.017</resource>
						</doi_data>
					</component>
					<component parent_relation="isReferencedBy">
						<titles>
							<title>Supplementary file 1.List of validated targets that were alternatively spliced after
									pilocarpine induced status epilepticus.</title>
							<subtitle>Targets were grouped
								according to their biological process and molecular function.
								Calculated delta I (&#x0394;I) was listed for both the hippocampus
								(Hp) and cortex (Ctx) at 4 hr and 24 hr time points. &#x0394;I from
								exon junction arrays are listed; other exons were empirically
								examined. Total fold change (TFC) of transcript level was calculated
								as the signal from status epilepticus divided by the signal of sham
								in the hippocampus. Alternative splice (AS) type is also listed,
								with abbreviations as follows: CASS: cassette exon; ALT5:
								alternative 5&#x2032; splice sites; ALT3: alternative 3&#x2032;
								splice sites; MUTX: mutually exclusive exons; IRET: retained intron;
								APA3: alternative polyA usage coupled with 3&#x2032; splice site
								selection; ALTP: alternative promoter; TACA: tandem cassette
								exons.</subtitle>
						</titles>
						<format mime_type="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
						<doi_data>
							<doi>10.7554/eLife.00178.028</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.028</resource>
						</doi_data>
					</component>
					<component parent_relation="isReferencedBy">
						<titles>
							<title>Supplementary file 2. PCR primers used in this work. All PCR
								primers are shown, oriented 5&#x2032; to 3&#x2032;.</title>
						</titles>
						<format mime_type="application/msword"/>
						<doi_data>
							<doi>10.7554/eLife.00178.029</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.029</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>
								<b>Decision letter</b>
							</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.030</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.030</resource>
						</doi_data>
					</component>
					<component parent_relation="isPartOf">
						<titles>
							<title>
								<b>Author response</b>
							</title>
						</titles>
						<format mime_type="text/plain"/>
						<doi_data>
							<doi>10.7554/eLife.00178.031</doi>
							<resource>http://elifesciences.org/lookup/doi/10.7554/eLife.00178.031</resource>
						</doi_data>
					</component>
				</component_list>
			</journal_article>
		</journal>
	</body>
</doi_batch>